Lentivirus-GPVI mab (1Q0J2U) WT Cas9-SERPINA3 for B Cell Engineering (CAT#: BGS-0524-CR126)

The product is a highly efficient, inducible WT Cas9-SERPINA3 gene-editing based novel Lentivirus packaging system that can be used to mediate researches involving anti-GPVI mab (1Q0J2U) in Horse B cell engineering.

Datasheet

Specifications

Clone 1Q0J2U
Host Human
Packaging Cell Line HEK 293
Vector Promoter U6
Rep Rep68
Capsid P24
Envelope Env
Matrix C-terminal
Size ~22kb
Genome dsDNA
Virus Type Lentivirus
Cofactor Requirement No ATP, CP, or CPK
Particles/mL 3.2 × 10¹¹
PFU/mL 3.5 × 10¹¹
TU/mL 7.8 × 10¹¹
Cas9 WT Cas9
sgRNA SERPINA3
Engineered B Cell Horse B cells

Target Information

Target GPVI
Alternative Names GPVI

Product Properties

Format Liquid
Shipping The product is shipped by dry ice.
Storage Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles.
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products